Literature DB >> 9531974

Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells.

C C Chua1, R C Hamdy, B H Chua.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent mitogen for endothelial cells and a vascular permeability factor. In this study we found that the addition of angiotensin II (AII) to rat heart endothelial cells induced VEGF mRNA production. VEGF mRNA levels reached a plateau within 2 h after the addition of AII and decreased after 4 h. The induction was superinduced by cycloheximide and blocked by actinomycin D. Losartan, an AT1 receptor antagonist, abolished the induction of VEGF mRNA by AII, whereas PD 123319, an AT2 receptor antagonist, had no effect on VEGF mRNA induction. H7, a protein kinase C inhibitor, blocked the induction. RT-PCR experiments showed two mRNA species (VEGF 120 and VEGF 164) in these cells and both species were stimulated by AII. Transient transfection experiment showed that VEGF promoter activity was increased 2.2-fold upon AII stimulation. Electrophoretic mobility shift assay revealed an enhanced binding of transcription factors AP-1 and NF-kappa B. Immunoblot analysis showed that the amount of secreted VEGF was elevated in the medium 8 h after AII stimulation. Our results demonstrate for the first time that the upregulation of VEGF by AII may play a significant role in AII-induced hyperpermeability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531974     DOI: 10.1016/s0167-4889(97)00129-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  37 in total

1.  Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation.

Authors:  Micheline M de Resende; Andrew S Greene
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-25       Impact factor: 4.733

2.  Angiotensin II-induced process of angiogenesis is mediated by spleen tyrosine kinase via VEGF receptor-1 phosphorylation.

Authors:  Cuneyt K Buharalioglu; Chi Young Song; Fariborz A Yaghini; Hafiz U B Ghafoor; Mustafa Motiwala; Tusita Adris; Anne M Estes; Kafait U Malik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-03       Impact factor: 4.733

3.  Systemic oxygen therapy versus oral enalapril for treatment of diabetic macular ischemia: a randomized controlled trial.

Authors:  Farideh Sharifipour; Mohammadreza Razzaghi; Alireza Ramezani; Mohsen Azarmina; Mehdi Yaseri; Roham Soheilian; Masoud Soheilian
Journal:  Int Ophthalmol       Date:  2015-08-21       Impact factor: 2.031

4.  The expression of angiotensin and endothelin system members in bovine corpus luteum during estrous cycle and pregnancy.

Authors:  Bajram Berisha; Dieter Schams; Akio Miyamoto
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

Review 5.  Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide.

Authors:  Jing Zheng; Ian M Bird; Dong-Bao Chen; Ronald R Magness
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

6.  Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: a retrospective examination.

Authors:  Daniel Keizman; Peng Huang; Mario A Eisenberger; Roberto Pili; Jenny J Kim; Emmanuel S Antonarakis; Hans Hammers; Michael A Carducci
Journal:  Eur J Cancer       Date:  2011-05-18       Impact factor: 9.162

7.  Mitigation of radiation myelopathy and reduction of microglial infiltration by Ramipril, ACE inhibitor.

Authors:  Mariano G Clausi; Alexander M Stessin; Stella E Tsirka; Samuel Ryu
Journal:  Spinal Cord       Date:  2018-06-14       Impact factor: 2.772

8.  Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo.

Authors:  Ajay Sharma; Daniel I Bettis; John W Cowden; Rajiv R Mohan
Journal:  Mol Vis       Date:  2010-04-23       Impact factor: 2.367

9.  Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study.

Authors:  Lauren Anton; David C Merrill; Liomar A A Neves; Courtney Gruver; Cheryl Moorefield; K Bridget Brosnihan
Journal:  Reprod Biol Endocrinol       Date:  2010-11-04       Impact factor: 5.211

10.  Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor.

Authors:  Lauren Anton; David C Merrill; Liomar A A Neves; K Bridget Brosnihan
Journal:  Endocrine       Date:  2007-11-15       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.